Skip to main content
Erschienen in: Pediatric Cardiology 2/2006

01.04.2006

Left Ventricular Diastolic Dysfunction in Children and Young Adults with Marfan Syndrome

verfasst von: B.B. Das, A.L. Taylor, A.T. Yetman

Erschienen in: Pediatric Cardiology | Ausgabe 2/2006

Einloggen, um Zugang zu erhalten

Abstract

Adults with Marfan syndrome (MFS) demonstrate abnormal aortic elastic properties manifest by decreased aortic distensibility and increased aortic stiffness. Left ventricular (LV) diastolic dysfunction has been reported in adults with MFS. The objective of this study was to assess the frequency of LV diastolic dysfunction in a group of children and young adults with MFS and to determine whether diastolic dysfunction is associated with hemodynamic alterations of the aorta. Review of echocardiographic findings in 40 patients with MFS was performed to assess LV size, systolic function, isovolumic relaxation time (IVRT), mitral inflow velocities, deceleration time (DT) of mitral E wave, and aortic root dimension. No patient had significant valvar disease or was on any cardiac medication at the time of study. A group of 40 age and sex-matched healthy subjects undergoing echocardiography served as controls. Significant differences in LV diastolic function were found between MFS patients and controls. MFS patients had prolonged DT and IVRT and decreased mitral E/A ratio, suggesting impaired LV relaxation. No relationship between aortic root dimension and diastolic performance was identified. Left ventricular diastolic dysfunction may be an early marker of myocardial involvement in young MFS patients occurring independently of aortic root dilatation.
Literatur
1.
Zurück zum Zitat Daubeney PEF, Blackstone EH, Weintraub RG, et al. (1999) Relationship of the dimension of cardiac structures to body size: an echocardiographic study in normal infants and children. Cardiol Young 9:402–410PubMed Daubeney PEF, Blackstone EH, Weintraub RG, et al. (1999) Relationship of the dimension of cardiac structures to body size: an echocardiographic study in normal infants and children. Cardiol Young 9:402–410PubMed
2.
Zurück zum Zitat De.Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyertiz RE (1996) Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62:417–426CrossRefPubMed De.Paepe A, Devereux RB, Dietz HC, Hennekam RC, Pyertiz RE (1996) Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet 62:417–426CrossRefPubMed
3.
Zurück zum Zitat Dietz HC, Cutting GR, Pyertiz RE, et al. (1991) Marfan syndrome caused by a recurrent de novo missence mutation in the fibrillin gene. Nature 352:337–397CrossRefPubMed Dietz HC, Cutting GR, Pyertiz RE, et al. (1991) Marfan syndrome caused by a recurrent de novo missence mutation in the fibrillin gene. Nature 352:337–397CrossRefPubMed
4.
Zurück zum Zitat Hirata K, Triposkiadis F, Sparks E, et al. (1991) The Marfan syndrome: abnormal elastic properties.J Am Coll Cardiol 18:57–63PubMed Hirata K, Triposkiadis F, Sparks E, et al. (1991) The Marfan syndrome: abnormal elastic properties.J Am Coll Cardiol 18:57–63PubMed
5.
Zurück zum Zitat Oh JK, Appleton CP, Hatle LK, et al. (1997) The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 10:246–270PubMed Oh JK, Appleton CP, Hatle LK, et al. (1997) The noninvasive assessment of left ventricular diastolic function with two-dimensional and Doppler echocardiography. J Am Soc Echocardiogr 10:246–270PubMed
6.
Zurück zum Zitat Porciani MC, Giurlani L, Chelucci A, et al. (2002) Diastolic subclinical primary alterations in Marfan syndrome and Marfan-related disorder. Clin Cardiol 25:416–420PubMed Porciani MC, Giurlani L, Chelucci A, et al. (2002) Diastolic subclinical primary alterations in Marfan syndrome and Marfan-related disorder. Clin Cardiol 25:416–420PubMed
8.
Zurück zum Zitat Reed CM, Fox ME, Alpert BS (1993) Aortic biochemical properties in pediatric patients with the Marfan syndrome, and the effects of atenolol. Am J Cardiol 71:606–608PubMed Reed CM, Fox ME, Alpert BS (1993) Aortic biochemical properties in pediatric patients with the Marfan syndrome, and the effects of atenolol. Am J Cardiol 71:606–608PubMed
9.
Zurück zum Zitat Robinson PN, Godfrey M (2000) The molecular genetics of Marfan syndrome and related microfibrillopathies. J Med Genet 37:9–25CrossRefPubMed Robinson PN, Godfrey M (2000) The molecular genetics of Marfan syndrome and related microfibrillopathies. J Med Genet 37:9–25CrossRefPubMed
10.
Zurück zum Zitat Rozendaal L, Groenink M, Naeff MS, et al. (1998) Marfan syndrome in children and adolescents: an adjusted nomogram for screening aortic root dilatation. Heart 79:69–72PubMed Rozendaal L, Groenink M, Naeff MS, et al. (1998) Marfan syndrome in children and adolescents: an adjusted nomogram for screening aortic root dilatation. Heart 79:69–72PubMed
11.
Zurück zum Zitat Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) The committee on M-mode standardization of the American Society of Echocardiography. Recommendation regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072–1083PubMed Sahn DJ, DeMaria A, Kisslo J, Weyman A (1978) The committee on M-mode standardization of the American Society of Echocardiography. Recommendation regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58:1072–1083PubMed
12.
Zurück zum Zitat Sakai LY Keene DR, Engvall E (1986) Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 103:2499–2509PubMed Sakai LY Keene DR, Engvall E (1986) Fibrillin, a new 350-kD glycoprotein, is a component of extracellular microfibrils. J Cell Biol 103:2499–2509PubMed
13.
Zurück zum Zitat Savolainen A, Nisula L, Keto P, et al. (1994) Left ventricular function in children with theMarfon syndrome. Eur Heart J 15:625–630PubMed Savolainen A, Nisula L, Keto P, et al. (1994) Left ventricular function in children with theMarfon syndrome. Eur Heart J 15:625–630PubMed
Metadaten
Titel
Left Ventricular Diastolic Dysfunction in Children and Young Adults with Marfan Syndrome
verfasst von
B.B. Das
A.L. Taylor
A.T. Yetman
Publikationsdatum
01.04.2006
Erschienen in
Pediatric Cardiology / Ausgabe 2/2006
Print ISSN: 0172-0643
Elektronische ISSN: 1432-1971
DOI
https://doi.org/10.1007/s00246-005-1139-5

Weitere Artikel der Ausgabe 2/2006

Pediatric Cardiology 2/2006 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.